Skip to main content

Table 3 Unadjusted and adjusted odds ratios for predictors of condom use in sexually active women stating use of contraception at 6-month follow-up (n = 165)

From: Sexually transmitted infections and use of contraceptives in women living with HIV in Denmark – the SHADE cohort

Predictors of condom use

No condom use (n = 63)

Condom use (n = 102)

Unadjusted odds ratios

p-value

Mutually adjusted odds ratios1

p-value

Age at 1 February 2011 (inclusion), (years)

 >50

15 (57.7)

11 (42.3)

1.00

1.00

 30–49

44 (34.9)

82 (65.1)

2.54 (1.08–6.00)

0.034

2.30 (0.66–7.99)

0.19

 18–29

4 (30.8)

9 (69.2)

3.07 (0.75–12.59)

0.12

1.14 (0.11–11.54)

0.91

 (missing)

(0)

(0)

    

 Combined p-value

   

0.089

 

0.36

Race, n (%)

 White

27 (38.6)

43 (61.4)

1.00

1.00

 Asian

11 (45.8)

13 (54.2)

0.74 (0.29–1.89)

0.53

0.62 (0.19–2.07)

0.44

 Black

24 (34.3)

46 (65.7)

1.20 (0.60–2.40)

0.60

0.66 (0.25–1.72)

0.39

 (missing)

(1)

(0)

    

 Combined p-value

   

0.60

 

0.64

HIV RNA at inclusion, n (%)2

 Undetectable

45 (35.2)

83 (64.8)

1.00

1.00

 Detectable

13 (54.2)

11 (45.8)

0.46 (0.19–1.11)

0.083

0.86 (0.30–2.49)

0.78

 (missing)

(5)

(8)

    

 Combined p-value

   

0.083

 

0.78

Lifetime sexual partners at inclusion, n (%)

 <4

22 (47.8)

24 (52.2)

1.00

1.00

 5–14

25 (36.8)

43 (63.2)

1.58 (0.74–3.37)

0.24

1.40 (0.52–3.79)

0.51

 15–25

9 (34.6)

17 (65.4)

1.73 (0.64–4.68)

0.28

0.94 (0.23–3.80)

0.93

 >25

7 (28.0)

18 (72.0)

2.36 (0.83–6.72)

0.11

0.96 (0.23–4.00)

0.96

 (missing)

(0)

(0)

    

 Combined p-value

   

0.38

 

0.85

Marital status, n (%)

 Married

35 (41.2)

50 (58.8)

1.00

1.00

 Cohabitating

17 (53.1)

15 (46.9)

0.62 (0.27–1.40)

0.25

0.55 (0.20–1.50)

0.24

 Regular partner (not cohabitating)

8 (33.3)

16 (66.7)

1.40 (0.54–3.63)

0.49

1.01 (0.31–3.23)

0.99

 Single

3 (12.5)

21 (87.5)

4.90 (1.36–17.70)

0.015

0.99

 (missing)

(0)

(0)

    

 Combined p-value

   

0.030

 

0.67

Partner’s HIV status, n (%)

 HIV-positive

30 (68.2)

14 (31.8)

1.00

1.00

 HIV-negative

27 (28.7)

67 (71.3)

5.32 (2.45–11.55)

<0.000

3.89 (1.49–10.11)

0.0054

 Not tested/do not know

2 (50.0)

2 (50.0)

2.14 (0.27–16.81)

1

1.01 (0.05–19.87)

0.99

 (missing)

(4)

(19)

 

0.47

  

 Combined p-value

   

0.0001

 

0.014

Selfreported HSV3 infection prior to inclusion, n (%)

 Yes

14 (43.8)

18 (56.2)

1.00

1.00

 No

40 (36.0)

71 (64.0)

1.38 (0.62–3.07)

0.43

1.75 (0.66–4.63)

0.26

 Do not know (missing)

9 (40.9)

13 (59.1)

1.12 (0.37–3.38)

0.84

1.63 (0.43–6.25)

0.47

 Combined p-value

   

0.70

 

0.53

  1. 1The validity of the model was tested using the Hosmer and Lemeshow Goodness-of-Fit Test, 2HIV-RNA <40 copies/ml, 3HSV = Herpes simplex virus infection